Literature DB >> 1421164

GTPase activating proteins.

G Bollag1, F McCormick.   

Abstract

Since Ras proteins negotiate many signalling pathways leading to cell growth or differentiation, the regulation of Ras activity is vital to cellular health. Ras activity, which derives from a collaboration between Ras and GTP, is terminated by the GTPase activating protein (GAP)-catalyzed hydrolysis of the GTP. Hence, a simple regulatory scheme emerges: extracellular signals control Ras activity via membrane receptors and GAPs. However, the signalling scenario is probably not so simple. In looking for factors which interpret Ras activity, researchers have been led to the same factors which also regulate Ras activity, namely the GAPs. Therefore, it may be that Ras proteins are actually regulators of GAPs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421164

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

Review 1.  Thinking outside the box about Ras.

Authors:  John M Kyriakis
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

2.  TC21 causes transformation by Raf-independent signaling pathways.

Authors:  S M Graham; A B Vojtek; S Y Huff; A D Cox; G J Clark; J A Cooper; C J Der
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

Review 3.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

Review 4.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

5.  Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.

Authors:  J C Cheng; A R Frackelton; E L Bearer; P S Kumar; B Kannan; A Santos-Moore; A Rifai; J Settleman; J W Clark
Journal:  Cell Growth Differ       Date:  1995-02

6.  Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.

Authors:  S M Graham; A D Cox; G Drivas; M G Rush; P D'Eustachio; C J Der
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 7.  Molecularly targeted therapy for pediatric brain tumors.

Authors:  Warren K E
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.506

8.  Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors.

Authors:  M Crul; G J de Klerk; M Swart; L Weiner; P A Palmer; C J Bol; J H Beijnen; J H M Schellens
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.